Fertility preservation in female classic galactosemia patients

View/ Open
Author
van Erven, Britt
Gubbels, Cynthia S
van Golde, Ron J
Dunselman, Gerard A
Derhaag, Josien G
de Wert, Guido
Geraedts, Joep P
Bosch, Annet M
Treacy, Eileen P
Rubio-Gozalbo, M Estela
Note: Order does not necessarily reflect citation order of authors.
Published Version
https://doi.org/10.1186/1750-1172-8-107Metadata
Show full item recordCitation
van Erven, B., C. S. Gubbels, R. J. van Golde, G. A. Dunselman, J. G. Derhaag, G. de Wert, J. P. Geraedts, et al. 2013. “Fertility preservation in female classic galactosemia patients.” Orphanet Journal of Rare Diseases 8 (1): 107. doi:10.1186/1750-1172-8-107. http://dx.doi.org/10.1186/1750-1172-8-107.Abstract
Almost every female classic galactosemia patient develops primary ovarian insufficiency (POI) as a diet-independent complication of the disease. This is a major concern for patients and their parents, and physicians are often asked about possible options to preserve fertility. Unfortunately, there are no recommendations on fertility preservation in this group. The unique pathophysiology of classic galactosemia with a severely reduced follicle pool at an early age requires an adjusted approach. In this article recommendations for physicians based on current knowledge concerning galactosemia and fertility preservation are made. Fertility preservation is only likely to be successful in very young prepubertal patients. In this group, cryopreservation of ovarian tissue is currently the only available technique. However, this technique is not ready for clinical application, it is considered experimental and reduces the ovarian reserve. Fertility preservation at an early age also raises ethical questions that should be taken into account. In addition, spontaneous conception despite POI is well described in classic galactosemia. The uncertainty surrounding fertility preservation and the significant chance of spontaneous pregnancy warrant counseling towards conservative application of these techniques. We propose that fertility preservation should only be offered with appropriate institutional research ethics approval to classic galactosemia girls at a young prepubertal age.Other Sources
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3718676/pdf/Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAACitable link to this page
http://nrs.harvard.edu/urn-3:HUL.InstRepos:11717613
Collections
- HMS Scholarly Articles [17714]
Contact administrator regarding this item (to report mistakes or request changes)